Chinese ADR delisting threat looms over ETFs
More than 95% of one Invesco ETF is in Chinese ADRs and an iShares ETF is the largest holder of five facing delisting
The US Securities and Exchange Commission has moved closer to delisting certain Chinese companies, identifying the first batch of five that will have to provide proof of audit compliance by the end of March. Failing to do so means they will have to delist from New York’s stock exchange by 2024.
The five companies are Yum China, ACM Research, BeiGene, HutchMed and Zai Lab.
这五家企业是百胜中国(Yum China)、盛美半导体(ACM Research)、百济神州(BeiGene)、和黄医药(HutchMed)和再鼎医药(Zai Lab)。